New Key Statistics Module, Z-Score and F-Score
TSXV:IPCI.H Key Ratios
Market Cap C$ M | 2.65 |
Enterprise Value C$ M | 5.12 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | -- |
Price/Sales | 2.16 |
Price/Free Cash Flow | 11.43 |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) C$ M | 1.00 |
EPS (TTM) C$ | -0.12 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | 32.80 |
5-y EBITDA Growth Rate % | 54.80 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -1.32 |
EV-to-EBITDA | -1.40 |
PEG | -- |
Shares Outstanding M | 33.09 |
Net Margin (%) | -350.12 |
Operating Margin % | -279.12 |
Pre-tax Margin (%) | -343.98 |
Quick Ratio | 0.06 |
Current Ratio | 0.06 |
ROA % (ttm) | -205.83 |
ROE % (ttm) | -- |
ROIC % (ttm) | -77.92 |
Dividend Yield % | -- |
Altman Z-Score | -111.84 |
TSXV:IPCI.H Number of Guru Trades
TSXV:IPCI.H Volume of Guru Trades
Gurus Latest Trades with TSXV:IPCI.H
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
TSXV:IPCI.H is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
IntelliPharmaCeutics International Inc Insider Transactions
No Available Data